Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Women and Ischemic Heart Disease. Evolving Knowledge
Leslee J. Shaw
, Raffaelle Bugiardini
, C. Noel Bairey Merz
Research output
:
Contribution to journal
›
Review article
›
peer-review
602
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Women and Ischemic Heart Disease. Evolving Knowledge'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Coronary Artery Disease
100%
Ischemic Heart Disease
100%
Emerging Knowledge
100%
Heart Disease in Women
100%
Adverse Outcomes
75%
Obstructive Coronary Artery Disease
75%
Ischemia
50%
Quality of Life
25%
Therapeutic Regimen
25%
Sex Differences
25%
Therapeutic Strategies
25%
Non-obstructive Coronary Artery Disease
25%
Women's Experiences
25%
Low Dose Rate
25%
ST-elevation Myocardial Infarction (STEMI)
25%
Risk Reduction
25%
Myocardial Ischemia
25%
Symptom Burden
25%
Endothelial Function
25%
Functional Capacity
25%
Novel Risk Factors
25%
Non-invasive Imaging
25%
Inflammatory Markers
25%
Symptomatic Outcome
25%
Reproductive Hormones
25%
Microvascular Dysfunction
25%
Conservative Management
25%
Framingham Risk Score
25%
Interventional Strategies
25%
Coronary Reactivity
25%
Antianginal
25%
Capacity Measurement
25%
Antiischemic Therapy
25%
Preserved Systolic Function
25%
Low Burden
25%
Impact Evaluation
25%
Medicine and Dentistry
Coronary Artery Disease
100%
Ischemic Heart Disease
100%
Adverse Outcome
50%
Biological Marker
33%
Ischemia
33%
Quality of Life
16%
Acute Heart Infarction
16%
Conservative Treatment
16%
Functional Status
16%
Heart Muscle Ischemia
16%
Systolic Function
16%
Reproductive Hormone
16%
ST Elevation
16%
Framingham Risk Score
16%
Endothelial Function
16%
Sex Differences
16%
Negative Woman
16%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
100%
Ischemic Heart Disease
100%
Adverse Outcome
50%
Biological Marker
33%
Ischemia
33%
Heart Muscle Ischemia
16%
Acute Heart Infarction
16%
Functional Status
16%
Framingham Risk Score
16%